Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Medtronic
QuintilesIMS
Fuji
Farmers Insurance
Accenture
Cerilliant
Chubb
Moodys
Citi

Generated: August 16, 2017

DrugPatentWatch Database Preview

Cefdinir - Generic Drug Details

« Back to Dashboard

What are the generic sources for cefdinir and what is the scope of cefdinir patent protection?

Cefdinir
is the generic ingredient in two branded drugs marketed by Orchid Hlthcare, Sandoz, Teva Pharms, Aurobindo Pharma, Abbvie, and Lupin, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for cefdinir. Twenty-nine suppliers are listed for this compound.

Summary for Generic Name: cefdinir

Tradenames:2
Patents:0
Applicants:6
NDAs:12
Drug Master File Entries: see list12
Suppliers / Packagers: see list29
Bulk Api Vendors: see list85
Clinical Trials: see list20
Patent Applications: see list4,605
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cefdinir at DailyMed

Pharmacology for Ingredient: cefdinir

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma
CEFDINIR
cefdinir
FOR SUSPENSION;ORAL065473-002Dec 14, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin
CEFDINIR
cefdinir
FOR SUSPENSION;ORAL065259-001May 31, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Orchid Hlthcare
CEFDINIR
cefdinir
FOR SUSPENSION;ORAL065429-001Jul 18, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
CEFDINIR
cefdinir
CAPSULE;ORAL065368-001May 9, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
CEFDINIR
cefdinir
FOR SUSPENSION;ORAL065332-001May 4, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cefdinir

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie
OMNICEF
cefdinir
CAPSULE;ORAL050739-001Dec 4, 1997► Subscribe► Subscribe
Abbvie
OMNICEF
cefdinir
FOR SUSPENSION;ORAL050749-002Jul 29, 2004► Subscribe► Subscribe
Abbvie
OMNICEF
cefdinir
FOR SUSPENSION;ORAL050749-001Dec 4, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Cerilliant
Julphar
Daiichi Sankyo
Covington
Chinese Patent Office
Baxter
UBS
Teva
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot